Facebook Instagram X-twitter Linkedin

DSIP (10mg)

Table of Contents

  • Quickstart Highlights

DSIP (Delta Sleep-Inducing Peptide) 10mg protocols focus on this naturally occurring neuropeptide studied for its potential role in regulating sleep architecture, stress response, and circadian rhythm balance. DSIP may support deeper, more restorative sleep and improved recovery through modulation of neuroendocrine signaling. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration
  • Typical dosing range: 100–300 mcg once daily (subcutaneous or intranasal in research settings)
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the DSIP regimen.

  • Goal: Support sleep quality, stress regulation, and recovery
  • Schedule: Once daily administration, typically before bedtime
  • Dose Range: 100–300 mcg per night
  • Timing: 30–60 minutes before sleep
  • Dosing Protocol

Suggested approach for the 10 mg vial format.

  • Start: 100 mcg before bedtime to assess response
  • Target: 200–300 mcg once daily
  • Frequency: Once per day (evening preferred)
  • Vial Duration: One 10 mg vial lasts approximately 30–100 days, depending on dose
  • Timing: Night administration is standard for circadian support
  • Mechanism of Action

DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide that has been studied for its influence on sleep regulation, stress adaptation, and hormonal balance. It is thought to interact with central nervous system pathways involved in sleep-wake cycles and may help normalize dysregulated sleep patterns.

Research suggests DSIP may modulate neurotransmitters and neuroendocrine hormones such as cortisol, potentially reducing stress-related arousal and promoting deeper non-REM sleep stages. Although its exact receptor targets are not fully understood, preclinical studies indicate it may influence hypothalamic activity and improve overall sleep efficiency.

  • Potential Benefits & Side Effects

Observations based on preclinical and limited human research.

Potential Benefits:

  • May improve sleep onset and sleep depth
  • May support stress reduction and relaxation
  • May enhance recovery through improved sleep quality
  • Potential regulation of circadian rhythm disruptions

Possible Side Effects:

  • Mild drowsiness or morning grogginess in some users
  • Occasional headache or fatigue
  • Injection-site irritation (if used subcutaneously)
  • Limited clinical data; long-term safety not fully established